Survival of patients with pseudomyxoma peritonei treated by serial debulking
- 16 August 2010
- journal article
- research article
- Published by Wiley in Colorectal Disease
- Vol. 12 (9), 868-872
- https://doi.org/10.1111/j.1463-1318.2009.01947.x
Abstract
Aim We evaluated the outcome of patients with pseudomyxoma peritonei (PMP) after traditional debulking. PMP is a clinical condition characterized by disseminated intraperitoneal mucinous tumours often accompanied by mucinous ascites derived usually from an appendiceal neoplasm. Patients with PMP have traditionally been treated by serial debulking, but aggressive cytoreduction followed by hyperthermic intraperitoneal chemotherapy is now advocated as standard treatment in PMP. Method The analysis included 33 consecutive patients with PMP who underwent traditional debulking surgery between June 1984 and August 2008. The patient characteristics and details of the treatment were analysed retrospectively. The primary end-point was survival. Results The overall 5- and 10-year survival rates were 67% and 31% respectively. The patients underwent an average of 3.2 ± 0.4 operations (range 1–10). Of 33 patients, 23 (70%) underwent only 1–3 operations. The 30-day operative mortality rate was 2.7%. However, four patients (12%) seemed to have achieved long-term disease-free survival of more than 5 years. Conclusions The 5-year survival is comparable with results achieved in patients receiving a combination of cytoreductive surgery and intraperitoneal chemotherapy, but in the long term, the latter seems superior.Keywords
This publication has 17 references indexed in Scilit:
- Peritoneal pseudomyxoma: results of a systematic policy of complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapyBritish Journal of Surgery, 2008
- Appendiceal neoplasms and pseudomyxoma peritonei: A population based studyEuropean Journal of Surgical Oncology, 2008
- Survival Analysis of Pseudomyxoma Peritonei Patients Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal ChemotherapyAnnals of Surgery, 2007
- Prospective Morbidity and Mortality Assessment of Cytoreductive Surgery Plus Perioperative Intraperitoneal Chemotherapy To Treat Peritoneal Dissemination of Appendiceal Mucinous MalignancyAnnals of Surgical Oncology, 2006
- Long-term Survival Following Treatment of Pseudomyxoma PeritoneiAnnals of Surgery, 2005
- Cytoreductive surgery and peri-operative intraperitoneal chemotherapy as a curative approach to pseudomyxoma peritonei syndromeEuropean Journal of Surgical Oncology, 2001
- Clinical presentation of the pseudomyxoma peritonei syndromeBritish Journal of Surgery, 2000
- Pseudomyxoma peritoneiBritish Journal of Surgery, 1998
- A Clinicopathologic Analysis of 109 Cases with Emphasis on Distinguishing Pathologic Features, Site of Origin, Prognosis, and Relationship to “Pseudomyxoma Peritonei”The American Journal of Surgical Pathology, 1995
- Pseudomyxoma Peritonei Long-Term Patient Survival with an Aggressive Regional ApproachAnnals of Surgery, 1994